Resultados de la búsqueda 221-230 of 11636 for Lymphoma red flag

  1. Hematología - Ensayos clínicos - Mayo Clinic

    This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or does ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... lymphoma. Ibrutinib may stop the growth of cancer ... 1) in patients with relapsed and/or refractory diffuse large B cell lymphoma (DLBCL) after receiving at ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

  7. Médicos y departamentos

    B-cell lymphomas. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480. Accessed Aug. 30, 2024.

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able ...

  9. Oncología (médica) - Ensayos clínicos

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

  10. Oncología (médica) - Ensayos clínicos

    Scottsdale/Phoenix, Ariz. This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL). Actinium Therapy ...